Endostar Combination With Chemotherapy and EGFR-TKI in Lung Cancer Rechallenging Treatment After Acquired Resistance.
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Clinical Trials Related to Lung Cancer
Related studies linked through entity extraction aliases.
A Clinical Research of CAR T Cells Targeting CEA Positive Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
NEoadjuvant Gefitinib fOllowed by Surgery and gefiTinib In unresectAble sTage III NSCLC With EGFR Mutations.
- Status
- WITHDRAWN
- Phase
- PHASE2
The Randomized Controlled Clinical Trial of Kushen Injection
- Status
- UNKNOWN
- Phase
- PHASE4
HS-PCI in Locally Advanced Adenocarcinoma of the Lung
- Status
- WITHDRAWN
- Phase
- NA
Cancer Development In Organ Transplant Recipients
- Status
- COMPLETED
- Phase
- N/A
A Feasibility Study of Chinese Herbs to Manage Cancer-related Symptoms in Patients With Advanced NSCLC
- Status
- COMPLETED
- Phase
- NA
Excretion of Acetylamantadine (AA) by Lung Cancer Patients During a Chemotherapy Regimen
- Status
- UNKNOWN
- Phase
- N/A
LCI-LUN-ABR-001: Carbo With Nab-Paclitaxel in Patients With Advanced NSCL Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Pain Management Smartphone Application for Patients With Stage III-IV Head and Neck Cancer Undergoing Radiation Therapy
- Status
- COMPLETED
- Phase
- NA
Evaluation of Continuous Positive Airway Pressure for Tumor Motion Management in Radiotherapy
- Status
- UNKNOWN
- Phase
- PHASE2
Comparison of Emergence and Oxygenation During One-lung Ventilation With Desflurane and Propofol Anesthesia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
The EMPrintâ„¢ Ablate and RESect Study in Patients With Metastatic Lung Tumors (EMPRESS)
- Status
- COMPLETED
- Phase
- NA
A Phase I/II Study of Ibrutinib in Previously Treated Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Open-label Prospective Cohort Trial of Curcumin Plus Tyrosine Kinase Inhibitors (TKI) for EGFR -Mutant Advanced NSCLC
- Status
- UNKNOWN
- Phase
- PHASE1
A Study of Epacadostat (INCB024360) in Combination With Durvalumab (MEDI4736) in Subjects With Selected Advanced Solid Tumors (ECHO-203)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Novel Lung Functional Imaging for Personalized Radiotherapy
- Status
- COMPLETED
- Phase
- NA
Identification of Predictive and Prognostic Markers for Lung Cancer With Metastases
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Personalized Sequence for Thoracic, Esophageal, and H&N Cancer
- Status
- UNKNOWN
- Phase
- N/A